Glioblastoma — device options

Prefer to look first? Browse the live map without signing up.

9 open options

TRIALNANOT_YET_RECRUITING
Exploration and Characterization Ofintratumoral Electrophysiological Heterogeneity in Gliomas Using Magnetoencephalography
MEG — 1 site
TRIALNANOT_YET_RECRUITING
Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
Neuropixel probe recording
TRIALNARECRUITING
Preoperative Preradiotherapy TTFields
TTFields — 1 site
TRIALNARECRUITING
Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases
Combined ultrasound and fluorescence-guided brain tumor resection · Fluorescence-guided brain tumor resection — 1 site
TRIALPHASE1RECRUITING
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Dual-target CAR-NK cells · Cyclophosphamide · Intracranial catheter/reservoir for locoregional delivery — 1 site
TRIALPHASE1 / PHASE2RECRUITING
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Near-Infrared Fluorescence Imaging · Panitumumab · Panitumumab-IRDye800 — 1 site
TRIALNANOT_YET_RECRUITING
Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma
GlioHook device — 3 sites
TRIALNARECRUITING
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Sonobiopsy · Research blood · Cancer Personalized Profiling — 1 site
TRIALNANOT_YET_RECRUITING
Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma
NaviFUS System · Lumason · Bevacizumab — 1 site

Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.